// App-Quantinova.ai

1408 : Risk factors for hyperprogressive disease in lung cancer patients using two different definitions

Researchers

Presenter

  • Trie Arni Djunadi

Principal Investigators

  • Youjin Oh

  • Liam Il-Young Chung

  • Timothy Hong

  • Soowon Lee

  • Zunairah Shah

  • Joo Hee Park

  • Sung Mi Yoon

  • Young Kwang Chae

Medical Centers

  • Baylor University, Waco, TX

  • Northwestern University, Evanston, IL

  • Feinberg School of Medicine, Northwestern University, Chicago, IL

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Lung Cancer

Biomarkers

  • Neutrophil lymphocyte ratio

  • Programmed death-ligand 1

  • Tumor mutational burden

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved